Literature DB >> 1171993

Biochemical studies on bovine adenovirus type 3. I. Purification and properties.

Y Niiyama, K Igarashi, K Tsukamoto, T Kurokawa, Y Sugino.   

Abstract

Bovine adenovirus type 3 (BAV3) was purified and its properties were studied. On productive infection of CKT1 cells (a cell line derived from calf kidney) with BAV3, it was observed that viral DNA synthesis was initiated after about 24 h and its rate was maximal after about 40 h. Maturation of the virus occurred several hours after this. Purified BAV3 was separated into four discrete bands by CsCl density gradient centrifugation (complete, incomplete, empty, and degraded viruses). The complete BAV3 was similar in size and structure to human and avian adenoviruses. Polyacrylamide gel electrophoresis showed that the complete BAV3 virion contained at least 10 polypeptides. The total structural proteins of the virion had a similar amino acid composition to those of human adenoviruses. DNA of the complete virus was a linear duplex and its contour length was 12.3 +/- 0.9 mum. The So20,w value of the DNA was 32.9S and its buoyant density in CsCl was 1.717 g/ml. There was about 25% homology between the DNAs of BAV3 and human adenovirus type 5 by filter hybridization. It was also noted that BAV3 produced incomplete virus. The incomplete virus was similar in morphology to the complete virus and contained almost all the structural polypeptides of the latter, but lacked infectivity. However, its DNA had a deletion(s) (13%) which seemed to locate near a terminal.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1171993      PMCID: PMC354710     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  43 in total

1.  A unique form of terminal redundancy in adenovirus DNA molecules.

Authors:  C F Garon; K W Berry; J A Rose
Journal:  Proc Natl Acad Sci U S A       Date:  1972-09       Impact factor: 11.205

Review 2.  Adenoviruses: the nature of the virion and of controlling factors in productive or abortive infection and tumorigenesis.

Authors:  R W Schlesinger
Journal:  Adv Virus Res       Date:  1969       Impact factor: 9.937

3.  Oncogenicity of bovine adenovirus type 3 in hamsters.

Authors:  J H Darbyshire
Journal:  Nature       Date:  1966-07-02       Impact factor: 49.962

4.  A new adenovirus serotype of bovine origin.

Authors:  J H Darbyshire; P S Dawson; P H Lamont; D C Ostler; H G Pereira
Journal:  J Comp Pathol       Date:  1965-07       Impact factor: 1.311

5.  The polypeptides of adenovirus. V. Young virions, structural intermediate between top components and aged virions.

Authors:  M Ishibashi; J V Maizel
Journal:  Virology       Date:  1974-02       Impact factor: 3.616

6.  Incomplete particles of adenovirus. I. Characteristics of the DNA associated with incomplete adenovirions of types 2 and 12.

Authors:  B T Burlingham; D T Brown; W Doerfler
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

7.  The polypeptides of adenovirus. II. Soluble proteins, cores, top components and the structure of the virion.

Authors:  J V Maizel; D O White; M D Scharff
Journal:  Virology       Date:  1968-09       Impact factor: 3.616

8.  Nonproductive infection and induction of cellular deoxyribonucleic acid synthesis by bovine adenovirus type 3 in a contact-inhibited mouse cell line.

Authors:  K Tsukamoto; Y Sugino
Journal:  J Virol       Date:  1972-03       Impact factor: 5.103

9.  Incomplete particles of adenovirus. II. Kinetics of formation and polypeptide composition of adenovirus type 2.

Authors:  B Rosenwirth; S Tjia; M Westphal; W Doerfler
Journal:  Virology       Date:  1974-08       Impact factor: 3.616

10.  Cleavage of adenovirus type 2 DNA into six unique fragments by endonuclease R-RI.

Authors:  U Pettersson; C Mulder; H Deluis; P A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  1973-01       Impact factor: 11.205

View more
  11 in total

1.  Nucleotide sequence, genome organization, and transcription map of bovine adenovirus type 3.

Authors:  P S Reddy; N Idamakanti; A N Zakhartchouk; M K Baxi; J B Lee; C Pyne; L A Babiuk; S K Tikoo
Journal:  J Virol       Date:  1998-02       Impact factor: 5.103

2.  Genome structure of incomplete particles of adenovirus.

Authors:  E Daniell
Journal:  J Virol       Date:  1976-08       Impact factor: 5.103

3.  Structural polypeptides of adenovirus type 16 incomplete particles.

Authors:  G Winberg; G Wadell
Journal:  J Virol       Date:  1977-05       Impact factor: 5.103

4.  Sequence homology between bovine and human adenoviruses.

Authors:  S L Hu; W W Hays; D E Potts
Journal:  J Virol       Date:  1984-02       Impact factor: 5.103

5.  Structure and function of adenovirus type 12 defective virions.

Authors:  I Mak; H Ezoe; S Mak
Journal:  J Virol       Date:  1979-10       Impact factor: 5.103

6.  The rate of hepatitis C virus infection initiation in vitro is directly related to particle density.

Authors:  Ali Sabahi; Katherine A Marsh; Harel Dahari; Peter Corcoran; Jennifer M Lamora; Xuemei Yu; Robert F Garry; Susan L Uprichard
Journal:  Virology       Date:  2010-08-25       Impact factor: 3.616

7.  Biochemical studies on bovine adenovirus type 3. III. Cleavage maps of viral DNA by restriction endoncleases EcoRI, BamHI, and HindIII.

Authors:  T Kurokawa; K Igarashi; Y Sugino
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

8.  Biochemical studies on bovine adenovirus type 3. IV. Transformation by viral DNA and DNA fragments.

Authors:  K Igarashi; R Sasada; T Kurokawa; Y Niiyama; K Tsukamoto; Y Sugino
Journal:  J Virol       Date:  1978-10       Impact factor: 5.103

9.  Isolation, identification, and complete genome sequence of a bovine adenovirus type 3 from cattle in China.

Authors:  Yuan-Mao Zhu; Zuo Yu; Hong Cai; Yu-Ran Gao; Xiu-Mei Dong; Zhao-Li Li; Hong-Fei Shi; Qing-Feng Meng; Chuang Lu; Fei Xue
Journal:  Virol J       Date:  2011-12-22       Impact factor: 4.099

10.  Packaging of viral RNAs in virions of adenoviruses.

Authors:  Li Xing; Suresh K Tikoo
Journal:  Virol J       Date:  2009-02-05       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.